The 2016 meeting of the International Cannabinoid Research Society focused on the latest research in cannabinoid studies and the endocannabinoid system.
Clinical endocannabinoid deficiency and ways to target the endocannabinoid system for therapeutic benefit.
Low-dose and high-dose treatments, protocols for chronic users, and the potential benefits of psychoactivity.
The current landscape of pesticides regulation, pest management, and the need for further research.
Lab testing, safety protocols, adverse events reporting, and regulatory standards for the cannabis industry.
CBD-rich drug plants, disappearing landrace strains, and the future of cannabis farming.
Kevin McKernan on sequencing the cannabis genome and its implications for the cannabis industry and “personalized medicine.”